C12N 2795/10145
Special targeting system for viral vectors
C12N2795/10145 (Special targeting system for viral vectors) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 6
- Assignees
- 3
- Inventors
- 14
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Bacteria-targeting capsid particle, treatment composition, disinfectant, food, bacteria elimination method, bactericidal method, corrosion prevention method, animal treatment method, gene introduction method, bacteria function addition method, method for producing bacteria-targeting capsid particle, and method for producing nucleic acid for bacteria-targeting capsid particle25 Dec 2025US 2025/0387442 A1Jichi Medical University
- Targeting e coli cells26 Jun 2025US 2025/0205293 A1SNIPR Biome ApS
- Engineered bacteriophage t4 nanoparticles as a potential targeted activator of hiv-1 latency in cd4+ human t-cells26 Jan 2023US 2023/0026666 A1The Catholic University of America
- Design of bacteriophage-based artificial viruses for human genome remodeling24 Mar 2022US 2022/0090139 A1The Catholic University of America
- Design of bacteriophage-based artificial viruses for human genome remodeling3 Feb 2022US 2022/0033850 A1The Catholic University of America
Most cited
By later US patents